Summary
- Current Price
- As of today, CLYM price is $15.52, up +6.37% on
- Current Price All-Time High
- CLYM price is currently -47.73% below its historical high of $29.69 set on
- Market Cap
- CLYM current market cap is $891M, up +464.58% over the past 365 days
- Revenue
- CLYM current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for CLYM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Climb Bio, Inc. |
| Ticker | NASDAQ: CLYM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | climbbio.com |
| Employees | 28 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $15.52 | |
| Price, 1D Change | +6.37% | |
| $891M | ||
| - | ||
| - | ||
| 1.80 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.88 | ||
| EPS, 1Y Change | +42.48% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | ELYM | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.88 | ||
| EPS Estimate | -$0.78 | |
| EPS Est. Change | +11.85% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $15.52 | |
| Price Target | $25.00 | - |
| Price Tgt. Change | +61.08% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$1.53 | - | |
| -$0.83 | -$0.88 | -6.76% | |
| -$0.78 | N/A | +11.85% | |
| -$1.01 | N/A | -14.32% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $500.00K | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $15.52 | |
| $8.71 | ||
| $14.04 | ||
| $9.73 | ||
| $14.06 | ||
| $0.32 | ||
| 1.80 | ||
| $1.29 | ||
| 53.59 | ||
| 104.79% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.88 | ||
| -$97.00K | ||
| - | ||
| -$67.88M | ||
| - | ||
| -$59.85M | ||
| - | ||
| -$67.79M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 15.16 | ||
| 15.16 | ||
| - | ||
| - | ||
| 70.53 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 3.72 | ||
| -10.98 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $160.47M | ||
| $101.08M | ||
| $167.74M | ||
| $105.85M | ||
| $7.27M | ||
| $6.98M | ||
| $541.00K | ||
| $256.00K | ||
| $2.27M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $59.85M | ||
| $67.79M | ||
| $97.00K | ||
| $0.00 | ||
| $97.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$54.36M | ||
| $2.83M | ||
| -$21.00K | ||
| $186.00K | ||
| -$54.54M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| B. Riley Securities | → | |
| BTIG | → | |
| Baird | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| Truist Securities | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
No data
Screeners with CLYM
FAQ
- What is the ticker symbol for Climb Bio, Inc.?
- The ticker symbol for Climb Bio, Inc. is NASDAQ:CLYM
- Does Climb Bio, Inc. pay dividends?
- No, Climb Bio, Inc. does not pay dividends
- What sector is Climb Bio, Inc. in?
- Climb Bio, Inc. is in the Healthcare sector
- What industry is Climb Bio, Inc. in?
- Climb Bio, Inc. is in the Biotechnology industry
- What country is Climb Bio, Inc. based in?
- Climb Bio, Inc. is headquartered in United States
- When did Climb Bio, Inc. go public?
- Climb Bio, Inc. initial public offering (IPO) was on August 10, 2021
- Is Climb Bio, Inc. in the S&P 500?
- No, Climb Bio, Inc. is not included in the S&P 500 index
- Is Climb Bio, Inc. in the NASDAQ 100?
- No, Climb Bio, Inc. is not included in the NASDAQ 100 index
- Is Climb Bio, Inc. in the Dow Jones?
- No, Climb Bio, Inc. is not included in the Dow Jones index
- When was Climb Bio, Inc. last earnings report?
- Climb Bio, Inc.'s most recent earnings report was on August 14, 2025
- When does Climb Bio, Inc. report earnings?
- The next expected earnings date for Climb Bio, Inc. is November 13, 2026
Data Sources & References
- CLYM Official Website climbbio.com
- CLYM Profile on Yahoo Finance finance.yahoo.com/quote/CLYM
- CLYM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/clym